APA (7th ed.) Citation

Valgimigli, M., Frigoli, E., Leonardi, S., Vranckx, P., Rothenbühler, M., Tebaldi, M., . . . Cortese, B. (2018). Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): Final 1-year results of a multicentre, randomised controlled trial. Lancet, 392(10150), 835. https://doi.org/10.1016/S0140-6736(18)31714-8

Chicago Style (17th ed.) Citation

Valgimigli, Marco, et al. "Radial Versus Femoral Access and Bivalirudin Versus Unfractionated Heparin in Invasively Managed Patients with Acute Coronary Syndrome (MATRIX): Final 1-year Results of a Multicentre, Randomised Controlled Trial." Lancet 392, no. 10150 (2018): 835. https://doi.org/10.1016/S0140-6736(18)31714-8.

MLA (9th ed.) Citation

Valgimigli, Marco, et al. "Radial Versus Femoral Access and Bivalirudin Versus Unfractionated Heparin in Invasively Managed Patients with Acute Coronary Syndrome (MATRIX): Final 1-year Results of a Multicentre, Randomised Controlled Trial." Lancet, vol. 392, no. 10150, 2018, p. 835, https://doi.org/10.1016/S0140-6736(18)31714-8.